Laetitia Seguin

2.2k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Laetitia Seguin is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Laetitia Seguin has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Oncology. Recurrent topics in Laetitia Seguin's work include Cell Adhesion Molecules Research (8 papers), Microtubule and mitosis dynamics (5 papers) and Glioma Diagnosis and Treatment (3 papers). Laetitia Seguin is often cited by papers focused on Cell Adhesion Molecules Research (8 papers), Microtubule and mitosis dynamics (5 papers) and Glioma Diagnosis and Treatment (3 papers). Laetitia Seguin collaborates with scholars based in France, United States and Switzerland. Laetitia Seguin's co-authors include David A. Cheresh, Sara M. Weis, Jay S. Desgrosellier, Maria F. Camargo, Chloé C. Féral, Aleksandra Franovic, Kathryn C. Elliott, Jacqueline Lesperance, Shumei Kato and Mayra Yebra and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Laetitia Seguin

22 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance

2015 538 citations Laetitia Seguin, Jay S. Desgrosellier et al. Trends in Cell Biology profile →

Peers

Countries citing papers authored by Laetitia Seguin

Since Specialization

Citations

This map shows the geographic impact of Laetitia Seguin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laetitia Seguin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laetitia Seguin more than expected).

Fields of papers citing papers by Laetitia Seguin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laetitia Seguin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laetitia Seguin. The network helps show where Laetitia Seguin may publish in the future.

Co-authorship network of co-authors of Laetitia Seguin

This figure shows the co-authorship network connecting the top 25 collaborators of Laetitia Seguin. A scholar is included among the top collaborators of Laetitia Seguin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laetitia Seguin. Laetitia Seguin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional transfer of integrin co-receptor CD98hc by small extracellular vesicles improves wound healing in vivo 2024 ·Matrix Biology ·(unknown), Soline Estrach, Laetitia Seguin, Laurence Cailleteau, Ayelet Levy, Daniel Aberdam, Chloé C. Féral	0
2	KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through Macropinocytosis 2022 ·Sub-cellular biochemistry ·Laetitia Seguin	2
3	Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells 2021 ·Communications Biology ·Laetitia Seguin, (unknown), Francesca Corlazzoli, (unknown), (unknown), (unknown), Mayra Yebra, Alexey Koval, Eliana Marinari, (unknown), (unknown), Mathilde Allard, Sten Ilmjärv, Vladimir L. Katanaev, Paul R. Walker, Karl-Heinz Krause, Valérie Dutoit, Jann N. Sarkaria, Pierre-Yves Dietrich, Érika Cosset	13
4	A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy 2021 ·Nature Communications ·Laëtitia Douguet, (unknown), Jonathan Benzaquen, Laetitia Seguin, Thierry Juhel, Xavier Dezitter, Christophe Duranton, Bernhard Ryffel, Jean Kanellopoulos, Cécile Delarasse, Nicolas Renault, Christophe Furman, (unknown), Chloé C. Féral, Julien Cherfils‐Vicini, Régis Millet, Sahil Adriouch, Alina Ghinet, Paul Hofman, Valérie Vouret‐Craviari	64
5	Dermal Fibroblast SLC3A2 Deficiency Leads to Premature Aging and Loss of Epithelial Homeostasis 2018 ·Journal of Investigative Dermatology ·(unknown), Soline Estrach, Etienne Boulter, Laurence Cailleteau, (unknown), Laetitia Seguin, Sabrina Pisano, Stéphane Audebert, Olivier Croce, Chloé C. Féral	10
6	Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers 2017 ·Cancer Discovery ·Laetitia Seguin, Maria F. Camargo, Hiromi I. Wettersten, Shumei Kato, Jay S. Desgrosellier, Tami Von Schalscha, Kathryn C. Elliott, Érika Cosset, Jacqueline Lesperance, Sara M. Weis, David A. Cheresh	84
7	Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma 2017 ·Annals of Oncology ·Érika Cosset, Sten Ilmjärv, Valérie Dutoit, Kathryn C. Elliott, Tami Von Schalscha, (unknown), Maria F. Camargo, Toshiro Moroishi, Laetitia Seguin, German G. Gomez, (unknown), Olivier Preynat‐Seauve, Karl‐Heinz Krause, Hervé Chneiweiss, Kun‐Liang Guan, Pierre‐Yves Dietrich, Sara M. Weis, Paul S. Mischel, David A. Cheresh	9
8	Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma 2017 ·Cancer Cell ·Érika Cosset, Sten Ilmjärv, Valérie Dutoit, Kathryn C. Elliott, Tami Von Schalscha, Maria F. Camargo, (unknown), Toshiro Moroishi, Laetitia Seguin, German G. Gomez, (unknown), Olivier Preynat‐Seauve, Karl‐Heinz Krause, Hervé Chneiweiss, Jann N. Sarkaria, Kun‐Liang Guan, Pierre-Yves Dietrich, Sara M. Weis, Paul S. Mischel, David A. Cheresh	128
9	Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence 2015 ·Cancer Research ·Aleksandra Franovic, Kathryn C. Elliott, Laetitia Seguin, Maria F. Camargo, Sara M. Weis, David A. Cheresh	34
10	Kinase-independent role for CRAF-driving tumour radioresistance via CHK2 2015 ·Nature Communications ·Sunil J. Advani, Maria F. Camargo, Laetitia Seguin, Ainhoa Mielgo, Sudarshan Anand, (unknown), Joseph Aguilera, Aleksandra Franovic, Sara M. Weis, David A. Cheresh	35
11	Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance breakdown → 2015 ·Trends in Cell Biology ·Laetitia Seguin, Jay S. Desgrosellier, Sara M. Weis, David A. Cheresh	538
12	An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition 2014 ·Nature Cell Biology ·Laetitia Seguin, Shumei Kato, Aleksandra Franovic, Maria F. Camargo, Jacqueline Lesperance, Kathryn C. Elliott, Mayra Yebra, Ainhoa Mielgo, Andrew M. Lowy, Hatim Husain, Tina Cascone, Lixia Diao, Jing Wang, Ignacio I. Wistuba, John V. Heymach, Scott M. Lippman, Jay S. Desgrosellier, Sudarshan Anand, Sara M. Weis, David A. Cheresh	298
13	Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland 2014 ·Developmental Cell ·Jay S. Desgrosellier, Jacqueline Lesperance, Laetitia Seguin, Maricel Gozo, Shumei Kato, Aleksandra Franovic, Mayra Yebra, Sanford J. Shattil, David A. Cheresh	78
14	Abstract 1916: β3 integrin/KRAS/RalB complex drives tumor stemness and resistance to EGFR inhibition 2014 ·Cancer Research ·Laetitia Seguin, Shumei Kato, Aleksandra Franovic, Maria F. Camargo, (unknown), Mayra Yebra, Jacqueline Lesperance, Ainhoa Mielgo, Jay S. Desgrosellier, Sudarshan Anand, Sara M. Weis, David A. Cheresh	10
15	A MEK-independent role for CRAF in mitosis and tumor progression 2011 ·Nature Medicine ·Ainhoa Mielgo, Laetitia Seguin, Miller Huang, Maria F. Camargo, Sudarshan Anand, Aleksandra Franovic, Sara M. Weis, Sunil J. Advani, Eric A. Murphy, David A. Cheresh	54
16	APCcdh1 Mediates Degradation of the Oncogenic Rho-GEF Ect2 after Mitosis 2011 ·PLoS ONE ·Caroline Liot, Laetitia Seguin, Aurélie Siret, Catherine Crouin, Susanne Schmidt, Jacques Bertoglio	31
17	Phosphoregulation of MgcRacGAP in mitosis involves Aurora B and Cdk1 protein kinases and the PP2A phosphatase 2008 ·FEBS Letters ·Aminata Touré, (unknown), Caroline Liot, Laetitia Seguin, (unknown), Catherine Crouin, (unknown), Yeou‐Guang Tsay, Olivier Dorseuil, Gérard Gâcon, Jacques Bertoglio	31
18	CUX1 and E2F1 Regulate Coordinated Expression of the Mitotic Complex Genes Ect2, MgcRacGAP, and MKLP1 in S Phase 2008 ·Molecular and Cellular Biology ·Laetitia Seguin, Caroline Liot, (unknown), Ryoko Harada, Aurélie Siret, Alain Nepveu, Jacques Bertoglio	43
19	Regulation of Rho signaling pathways in interleukin‐2‐stimulated human T‐lymphocytes 2005 ·The FASEB Journal ·(unknown), Laetitia Seguin, Caroline Liot, Anick Auger, Pierre Pacaud, Gervaise Loirand, Christelle Thibault-Carpentier, Josiane Pierre, Jacques Bertoglio	19
20	The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats 2004 ·Psychopharmacology ·(unknown), Laetitia Seguin, Alain P. Gobert, Didier Cussac, Mauricette Brocco	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact